[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:central-nervous-system-embryonal-tumor":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Central Nervous System Embryonal Tumor",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07087002","GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults",[11],"Phase 1","RECRUITING","2026-08-26T02:19:23.493898Z","2026-05-05T02:43:28.714199Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT04099797","C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)",[11],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:27.089113Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT07698899","A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)",[11],"2026-08-26T02:18:49.989941Z","2026-07-19T19:36:05.081790Z",[],[]]